Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
If your research requires absolutely clean IGF-1R-specific signalling without any insulin receptor cross-reactivity, DES is theoretically superior
Estes C, Razavi H, Loomba R, et al
This case underscores the growing tension between branded drug makers seeking to protect market share and compounding pharmacies leveraging clinical demand and legal frameworks to expand patient access
Insurance-covered brand-name medications remain the gold standard when accessible
By purchasing, you confirm these materials will be used strictly for research purposes by qualified personnel
US$ 22.01
US$ 25.45
US$ 21.90
.webp)
